<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32595261</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1333-9451</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Acta clinica Croatica</Title><ISOAbbreviation>Acta Clin Croat</ISOAbbreviation></Journal><ArticleTitle>COMPLEX TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS PATIENT.</ArticleTitle><Pagination><StartPage>757</StartPage><EndPage>766</EndPage><MedlinePgn>757-766</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.20471/acc.2019.58.04.24</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis is a progressive and fatal degenerative neuromuscular disease with few if any treatment options and physical rehabilitation addressing specific deficits is the most frequent form of therapy. Patients also suffer from depression and increased anxiety. Our purpose was to assess the neurorehabilitation effectiveness in a patient with amyotrophic lateral sclerosis who underwent stem cell transplantation but refused physiotherapy due to depression. Disease progression was followed using the revised Amyotrophic Lateral Sclerosis Functional Rating Scale bimonthly for six months pre- and then post-stem cell transplantation. Psychological traits were assessed using six standardized tests. Quantitative electroencephalogram diagnostics was performed before the first and after the last neurofeedback session, and sessions were conducted on a 3-times-a-week basis. The physiotherapy protocol included proprioceptive neuromuscular facilitation, electrical modalities unit applied to the lumbar spine area, and breathing, relaxation and walking exercises, among others. Increased motivation and marked decrease in the pain level was associated with the patient's willingness to complete physiotherapy, which resulted in improvements in most neuromuscular deficits and in increased respiratory capacity. During the 12 post-rehabilitation months, progression of the disease decelerated, and a positive behavioral change was noted. The study suggested that neurofeedback could be used as a neurorehabilitation component of the personalized complex rehabilitation protocol in patients with amyotrophic lateral sclerosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bia&#x142;kowska</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>1Department of Public Health, Faculty of Health Sciences, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland; 2Clinical University Hospital, Olsztyn, Poland; 3Department of Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland; 4Department of Neurology and Neurosurgery, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mroczkowska</LastName><ForeName>Dorota</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>1Department of Public Health, Faculty of Health Sciences, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland; 2Clinical University Hospital, Olsztyn, Poland; 3Department of Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland; 4Department of Neurology and Neurosurgery, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huflejt</LastName><ForeName>Margaret E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>1Department of Public Health, Faculty of Health Sciences, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland; 2Clinical University Hospital, Olsztyn, Poland; 3Department of Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland; 4Department of Neurology and Neurosurgery, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wojtkiewicz</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>1Department of Public Health, Faculty of Health Sciences, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland; 2Clinical University Hospital, Olsztyn, Poland; 3Department of Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland; 4Department of Neurology and Neurosurgery, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siwek</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>1Department of Public Health, Faculty of Health Sciences, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland; 2Clinical University Hospital, Olsztyn, Poland; 3Department of Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland; 4Department of Neurology and Neurosurgery, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barczewska</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>1Department of Public Health, Faculty of Health Sciences, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland; 2Clinical University Hospital, Olsztyn, Poland; 3Department of Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland; 4Department of Neurology and Neurosurgery, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maksymowicz</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>1Department of Public Health, Faculty of Health Sciences, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland; 2Clinical University Hospital, Olsztyn, Poland; 3Department of Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland; 4Department of Neurology and Neurosurgery, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Croatia</Country><MedlineTA>Acta Clin Croat</MedlineTA><NlmUniqueID>9425483</NlmUniqueID><ISSNLinking>0353-9466</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000534" MajorTopicYN="Y">rehabilitation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012046" MajorTopicYN="N">Rehabilitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Biofeedback, psychology</Keyword><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32595261</ArticleId><ArticleId IdType="pmc">PMC7314291</ArticleId><ArticleId IdType="doi">10.20471/acc.2019.58.04.24</ArticleId><ArticleId IdType="pii">acc-58-757</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3. 10.1186/1750-1172-4-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>del Aguila MA, Longstreth WT, Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology. 2003;60(5):813&#x2013;9. 10.1212/01.WNL.0000049472.47709.3B</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000049472.47709.3B</ArticleId><ArticleId IdType="pubmed">12629239</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsgren L, Almay BG, Holmgren G, Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand. 1983;68(1):20&#x2013;9. 10.1111/j.1600-0404.1983.tb04810.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1983.tb04810.x</ArticleId><ArticleId IdType="pubmed">6604389</ArticleId></ArticleIdList></Reference><Reference><Citation>Orsini M, Lial L, Moreira R, Bastos VH, Pupe C, Bittar C, et al. Rehabilitation in amyotrophic lateral sclerosis: prudence and limit of programs. Int J Phys Med Rehabil. 2015;2(9):1067.</Citation></Reference><Reference><Citation>Ng L, Khan F. Multidisciplinary rehabilitation in amyotrophic lateral sclerosis. In: Maurer M, editor. Amyotrophic Lateral Sclerosis. 2012; p. 557-78. IntechOpen, DOI: 10.5772/31774 Available from: https://www.intechopen.com/books/amyotrophic-lateral-sclerosis/multidisciplinary-rehabilitation-in-amyotrophic-lateral-sclerosis</Citation><ArticleIdList><ArticleId IdType="doi">10.5772/31774</ArticleId></ArticleIdList></Reference><Reference><Citation>Abresch RT, Han JJ, Carter GT. Rehabilitation management of neuromuscular disease: the role of exercise training. J Clin Neuromuscul Dis. 2009;11:7&#x2013;21. 10.1097/CND.0b013e3181a8d36b</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CND.0b013e3181a8d36b</ArticleId><ArticleId IdType="pubmed">19730017</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira GD, Costa AC, Plentz RD, Coronel CC, Sbruzzi G. Respiratory training improved ventilatory function and respiratory muscle strength in patients with multiple sclerosis and lateral amyotrophic sclerosis: systematic review and meta-analysis. Physiotherapy. 2016;102(3):221&#x2013;8. 10.1016/j.physio.2016.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physio.2016.01.002</ArticleId><ArticleId IdType="pubmed">27026167</ArticleId></ArticleIdList></Reference><Reference><Citation>Majmudar S, Wu J, Paganoni S. Rehabilitation in amyotrophic lateral sclerosis: why it matters. Muscle Nerve. 2014;50(1):4&#x2013;13. 10.1002/mus.24202</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24202</ArticleId><ArticleId IdType="pmc">PMC4433000</ArticleId><ArticleId IdType="pubmed">24510737</ArticleId></ArticleIdList></Reference><Reference><Citation>Budin&#x10d;evi&#x107; H, Budin&#x10d;evi&#x107; AM, Kos M, Vla&#x161;i&#x107; S, Bartolovi&#x107; J, Benko S, et al. Multidisciplinary management and neurorehabilitation of patients with amyotrophic lateral sclerosis. Acta Med Croatica. 2016;70(2):111&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28722839</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos E, Mariosa D, Ingre C, Lundholm C, Wirdefeldt K, Roos PM, et al. Depression in amyotrophic lateral sclerosis. Neurology. 2016;86(24):2271&#x2013;7. 10.1212/WNL.0000000000002671</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002671</ArticleId><ArticleId IdType="pmc">PMC4909561</ArticleId><ArticleId IdType="pubmed">27164661</ArticleId></ArticleIdList></Reference><Reference><Citation>van Groenestijn AC, Kruitwagen-van Reenen ET, Visser-Meily JM, van den Berg LH, Schr&#xf6;der CD. Associations between psychological factors and health-related quality of life and global quality of life in patients with ALS: a systematic review. Health Qual Life Outcomes. 2016;14(1):107. 10.1186/s12955-016-0507-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-016-0507-6</ArticleId><ArticleId IdType="pmc">PMC4955215</ArticleId><ArticleId IdType="pubmed">27439463</ArticleId></ArticleIdList></Reference><Reference><Citation>Bambini V, Arcara G, Martinelli I, Bernini S, Alvisi E, Moro A, et al. Communication and pragmatic breakdowns in amyotrophic lateral sclerosis patients. Brain Lang. 2016;153-154:1&#x2013;12. 10.1016/j.bandl.2015.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bandl.2015.12.002</ArticleId><ArticleId IdType="pubmed">26799425</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson M, Thompson L. The Neurofeedback Book: An Introduction to Basic Concepts in Applied Psychophysiology. Wheat Ridge, CO: Association for Applied Psychophysiology, 2003.</Citation></Reference><Reference><Citation>Micoulaud-Franchi JA, McGonigal A, Lopez R, Daudet C, Kotwas I, Bartolomei F. Electroencephalographic neurofeedback: level of evidence in mental and brain disorders and suggestions for good clinical practice. Neurophysiol Clin. 2015;45(6):423&#x2013;33. 10.1016/j.neucli.2015.10.077</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucli.2015.10.077</ArticleId><ArticleId IdType="pubmed">26553293</ArticleId></ArticleIdList></Reference><Reference><Citation>Yucha C, Montgomery D. Evidence-based practice in biofeedback and neurofeedback. Wheat Ridge, CO: Association for Applied Psychophysiology and Biofeedback, 2008. http://digitalscholarship.unlv.edu/nursing_fac_articles/1</Citation></Reference><Reference><Citation>Cheon EJ, Koo BH, Choi JH. The efficacy of neurofeedback in patients with major depressive disorder: an open labeled prospective study. Appl Psychophysiol Biofeedback. 2016;41(1):103&#x2013;10. 10.1007/s10484-015-9315-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10484-015-9315-8</ArticleId><ArticleId IdType="pubmed">26392114</ArticleId></ArticleIdList></Reference><Reference><Citation>Schabus M, Heib DP, Lechinger J, Griessenberger H, Klimesch W, Pawlizki A, et al. Enhancing sleep quality and memory in insomnia using instrumental sensorimotor rhythm conditioning. Biol Psychol. 2014;95:126&#x2013;34. 10.1016/j.biopsycho.2013.02.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsycho.2013.02.020</ArticleId><ArticleId IdType="pubmed">23548378</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorini A, Marzorati C, Casiraghi M, Spaggiari L, Pravettoni G. A neurofeedback-based intervention to reduce post-operative pain in lung cancer patients: study protocol for a randomized controlled trial. JMIR Res Protoc. 2015;4(2):e52. 10.2196/resprot.4251</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/resprot.4251</ArticleId><ArticleId IdType="pmc">PMC4436521</ArticleId><ArticleId IdType="pubmed">25940965</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterman MB. Biofeedback in the treatment of epilepsy. Cleve Clin J Med. 2010;77 Suppl 3:S60&#x2013;7. 10.3949/ccjm.77.s3.11</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.77.s3.11</ArticleId><ArticleId IdType="pubmed">20622079</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly JJ, Wolpaw JR. Brain-computer interfaces in neurological rehabilitation. Lancet Neurol. 2008;7(11):1032&#x2013;43. 10.1016/S1474-4422(08)70223-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70223-0</ArticleId><ArticleId IdType="pubmed">18835541</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew SL, Rana M, Cornelsen S, Fortunato de Barros Filho M, Birbaumer N, Sitaram R, et al. Improving motor corticothalamic communication after stroke using real-time fMRI connectivity-based neurofeedback. Neurorehabil Neural Repair. 2016;30(7):671&#x2013;5. 10.1177/1545968315619699</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1545968315619699</ArticleId><ArticleId IdType="pmc">PMC4907885</ArticleId><ArticleId IdType="pubmed">26671217</ArticleId></ArticleIdList></Reference><Reference><Citation>Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, Gomori JM, Kassis I, et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol. 2010;67(10):1187&#x2013;94. 10.1001/archneurol.2010.248</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.248</ArticleId><ArticleId IdType="pmc">PMC3036569</ArticleId><ArticleId IdType="pubmed">20937945</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrou P, Gothelf Y, Argov Z, Gotkine M, Levy YS, Kassis I, et al. Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1/2 and 2a clinical trials. JAMA Neurol. 2016;73(3):337&#x2013;44. 10.1001/jamaneurol.2015.4321</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.4321</ArticleId><ArticleId IdType="pubmed">26751635</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen GM, Gowing G, Svendsen S, Svendsen CN. The past, present and future of stem cell clinical trials for ALS. Exp Neurol. 2014;Pt B:127-37. DOI: 10.1016/j.expneurol.2014.02.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.02.021</ArticleId><ArticleId IdType="pubmed">24613827</ArticleId></ArticleIdList></Reference><Reference><Citation>Frausin S, Viventi S, Verga Falzacappa L, Quattromani MJ, Leanza G, Tommasini A, et al. Wharton&#x2019;s jelly derived mesenchymal stromal cells: biological properties, induction of neuronal phenotype and current applications in neurodegeneration research. Acta Histochem. 2015;117(4-5):329&#x2013;38. 10.1016/j.acthis.2015.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acthis.2015.02.005</ArticleId><ArticleId IdType="pubmed">25747736</ArticleId></ArticleIdList></Reference><Reference><Citation>Alunno A, Montanucci P, Bistoni O, Basta G, Caterbi S, Pescara T, et al. In vitro immunomodulatory effects of microencapsulated umbilical cord Wharton jelly-derived mesenchymal stem cells in primary Sj&#xf6;gren&#x2019;s syndrome. Rheumatology (Oxford). 2015;54(1):163&#x2013;8. 10.1093/rheumatology/keu292</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keu292</ArticleId><ArticleId IdType="pubmed">25065014</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Yang Q, Wang Z, Tong H, Ma L, Zhang Y, et al. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton&#x2019;s jelly as sources of cell immunomodulatory therapy. Hum Vaccin Immunother. 2016;12(1):85&#x2013;96. 10.1080/21645515.2015.1030549</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2015.1030549</ArticleId><ArticleId IdType="pmc">PMC4962749</ArticleId><ArticleId IdType="pubmed">26186552</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, et al. Research Group on ALS/MND. A revision of the El Escorial criteria - 2015. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5-6):291&#x2013;2. 10.3109/21678421.2015.1049183</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinetti ME, Williams TF, Mayewski R. Fall risk index for elderly patients based on number of chronic disabilities. Am J Med. 1986;80:429&#x2013;34. 10.1016/0002-9343(86)90717-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(86)90717-5</ArticleId><ArticleId IdType="pubmed">3953620</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterman MB. EEG biofeedback: physiological behavior modification. Neurosci Biobehav Rev. 1981;5(3):405&#x2013;12. 10.1016/0149-7634(81)90036-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0149-7634(81)90036-1</ArticleId><ArticleId IdType="pubmed">7301228</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrady A, Conran P, Dickey D, Garman D, Farris E, Schumann-Brzezinski C. The effects of biofeedback-assisted relaxation on cell-mediated immunity, cortisol, and white blood cell count in healthy adult subjects. J Behav Med. 1992;15(4):343&#x2013;54. 10.1007/BF00844727</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00844727</ArticleId><ArticleId IdType="pubmed">1404350</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaspina A, Puentes F, Amor S. Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective. Int Immunol. 2015;27(3):117&#x2013;29. 10.1093/intimm/dxu099</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxu099</ArticleId><ArticleId IdType="pubmed">25344935</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahia El Idrissi N, Bosch S, Ramaglia V, Aronica E, Baas F, Troost D. Complement activation at the motor end-plates in amyotrophic lateral sclerosis. J Neuroinflammation. 2016;13(1):72. 10.1186/s12974-016-0538-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0538-2</ArticleId><ArticleId IdType="pmc">PMC4823861</ArticleId><ArticleId IdType="pubmed">27056040</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Bender DE, Kashlan SR, Figueroa-Romero C, Backus C, Callaghan BC, et al. Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm. 2016;3(4):e242. 10.1212/NXI.0000000000000242</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000242</ArticleId><ArticleId IdType="pmc">PMC4897983</ArticleId><ArticleId IdType="pubmed">27308304</ArticleId></ArticleIdList></Reference><Reference><Citation>Czarzasta J, Habich A, Siwek T, Czapli&#x144;ski A, Maksymowicz W, Wojtkiewicz J. Stem cells for ALS: an overview of possible therapeutic approaches. Int J Dev Neurosci. 2017;57:46&#x2013;55. 10.1016/j.ijdevneu.2017.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijdevneu.2017.01.003</ArticleId><ArticleId IdType="pubmed">28088365</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin MR. Human psychoneuroimmunology: 20 years of discovery. Brain Behav Immun. 2008;22(2):129&#x2013;39. 10.1016/j.bbi.2007.07.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2007.07.013</ArticleId><ArticleId IdType="pubmed">17911004</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemeny ME, Schedlowski M. Understanding the interaction between psychosocial stress and immune-related diseases: a stepwise progression. Brain Behav Immun. 2007;21(8):1009&#x2013;18. 10.1016/j.bbi.2007.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2007.07.010</ArticleId><ArticleId IdType="pubmed">17889502</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004;5(10):617&#x2013;25. 10.1016/S1470-2045(04)01597-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(04)01597-9</ArticleId><ArticleId IdType="pubmed">15465465</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology. 2009;72(12):1087&#x2013;94. 10.1212/01.wnl.0000345041.83406.a2</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000345041.83406.a2</ArticleId><ArticleId IdType="pmc">PMC2821838</ArticleId><ArticleId IdType="pubmed">19307543</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, Diekmann V, Kassubek J, Kurt A, Birbaumer N, Ludolph AC, et al. Cortical plasticity in amyotrophic lateral sclerosis: motor imagery and function. Neurorehabil Neural Repair. 2007;21(6):518&#x2013;26. 10.1177/1545968307300698</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1545968307300698</ArticleId><ArticleId IdType="pubmed">17476000</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetti M, Piccione F, Silvoni S, Gamberini L, Priftis K. Covert visuospatial attention orienting in a brain-computer interface for amyotrophic lateral sclerosis patients. Neurorehabil Neural Repair. 2013;27(5):430&#x2013;8. 10.1177/1545968312471903</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1545968312471903</ArticleId><ArticleId IdType="pubmed">23353184</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>